 | • レポートコード：MRC2-11QY04701 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は特殊医薬品のグローバル市場について調査・分析したレポートです。種類別（経口医薬品、非経口医薬品、経皮吸収性医薬品）市場規模、用途別（病院、小売薬局、専門薬局、通信販売）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別特殊医薬品の競争状況、市場シェア ・世界の特殊医薬品市場：種類別市場規模 2015年-2020年（経口医薬品、非経口医薬品、経皮吸収性医薬品） ・世界の特殊医薬品市場：種類別市場規模予測 2021年-2026年（経口医薬品、非経口医薬品、経皮吸収性医薬品） ・世界の特殊医薬品市場：用途別市場規模 2015年-2020年（病院、小売薬局、専門薬局、通信販売） ・世界の特殊医薬品市場：用途別市場規模予測 2021年-2026年（病院、小売薬局、専門薬局、通信販売） ・北米の特殊医薬品市場分析：米国、カナダ ・ヨーロッパの特殊医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの特殊医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の特殊医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの特殊医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceuticals、Abbvie、Amgen、Johnson & Johnson、Celgene、Gilead Sciences、Roche ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs.
North America accounts the significant market share due to high buying power and reimbursement for the specialty pharmaceuticals are the major factors boosting the growth of this market during the forecast period.
Market Analysis and Insights: Global Specialty Pharmaceuticals Market
The global Specialty Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Specialty Pharmaceuticals Scope and Market Size
Specialty Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Teva Pharmaceuticals
Abbvie
Amgen
Johnson & Johnson
Celgene
Gilead Sciences
Roche
…
Market segment by Type, the product can be split into
Oral Pharmaceuticals
Parenteral Pharmaceuticals
Transdermal Pharmaceuticals
Market segment by Application, split into
Hospitals
Retail Pharmacies
Specialty Pharmacies
Mail Order
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Specialty Pharmaceuticals Revenue
1.4 Market by Type
1.4.1 Global Specialty Pharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Pharmaceuticals
1.4.3 Parenteral Pharmaceuticals
1.4.4 Transdermal Pharmaceuticals
1.5 Market by Application
1.5.1 Global Specialty Pharmaceuticals Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Retail Pharmacies
1.5.4 Specialty Pharmacies
1.5.5 Mail Order
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Specialty Pharmaceuticals Market Perspective (2015-2026)
2.2 Global Specialty Pharmaceuticals Growth Trends by Regions
2.2.1 Specialty Pharmaceuticals Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Specialty Pharmaceuticals Historic Market Share by Regions (2015-2020)
2.2.3 Specialty Pharmaceuticals Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Specialty Pharmaceuticals Market Growth Strategy
2.3.6 Primary Interviews with Key Specialty Pharmaceuticals Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Specialty Pharmaceuticals Players by Market Size
3.1.1 Global Top Specialty Pharmaceuticals Players by Revenue (2015-2020)
3.1.2 Global Specialty Pharmaceuticals Revenue Market Share by Players (2015-2020)
3.1.3 Global Specialty Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Specialty Pharmaceuticals Market Concentration Ratio
3.2.1 Global Specialty Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Specialty Pharmaceuticals Revenue in 2019
3.3 Specialty Pharmaceuticals Key Players Head office and Area Served
3.4 Key Players Specialty Pharmaceuticals Product Solution and Service
3.5 Date of Enter into Specialty Pharmaceuticals Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Specialty Pharmaceuticals Historic Market Size by Type (2015-2020)
4.2 Global Specialty Pharmaceuticals Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Specialty Pharmaceuticals Market Size by Application (2015-2020)
5.2 Global Specialty Pharmaceuticals Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Specialty Pharmaceuticals Market Size (2015-2020)
6.2 Specialty Pharmaceuticals Key Players in North America (2019-2020)
6.3 North America Specialty Pharmaceuticals Market Size by Type (2015-2020)
6.4 North America Specialty Pharmaceuticals Market Size by Application (2015-2020)
7 Europe
7.1 Europe Specialty Pharmaceuticals Market Size (2015-2020)
7.2 Specialty Pharmaceuticals Key Players in Europe (2019-2020)
7.3 Europe Specialty Pharmaceuticals Market Size by Type (2015-2020)
7.4 Europe Specialty Pharmaceuticals Market Size by Application (2015-2020)
8 China
8.1 China Specialty Pharmaceuticals Market Size (2015-2020)
8.2 Specialty Pharmaceuticals Key Players in China (2019-2020)
8.3 China Specialty Pharmaceuticals Market Size by Type (2015-2020)
8.4 China Specialty Pharmaceuticals Market Size by Application (2015-2020)
9 Japan
9.1 Japan Specialty Pharmaceuticals Market Size (2015-2020)
9.2 Specialty Pharmaceuticals Key Players in Japan (2019-2020)
9.3 Japan Specialty Pharmaceuticals Market Size by Type (2015-2020)
9.4 Japan Specialty Pharmaceuticals Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Specialty Pharmaceuticals Market Size (2015-2020)
10.2 Specialty Pharmaceuticals Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Specialty Pharmaceuticals Market Size by Type (2015-2020)
10.4 Southeast Asia Specialty Pharmaceuticals Market Size by Application (2015-2020)
11 India
11.1 India Specialty Pharmaceuticals Market Size (2015-2020)
11.2 Specialty Pharmaceuticals Key Players in India (2019-2020)
11.3 India Specialty Pharmaceuticals Market Size by Type (2015-2020)
11.4 India Specialty Pharmaceuticals Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Specialty Pharmaceuticals Market Size (2015-2020)
12.2 Specialty Pharmaceuticals Key Players in Central & South America (2019-2020)
12.3 Central & South America Specialty Pharmaceuticals Market Size by Type (2015-2020)
12.4 Central & South America Specialty Pharmaceuticals Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva Pharmaceuticals
13.1.1 Teva Pharmaceuticals Company Details
13.1.2 Teva Pharmaceuticals Business Overview
13.1.3 Teva Pharmaceuticals Specialty Pharmaceuticals Introduction
13.1.4 Teva Pharmaceuticals Revenue in Specialty Pharmaceuticals Business (2015-2020))
13.1.5 Teva Pharmaceuticals Recent Development
13.2 Abbvie
13.2.1 Abbvie Company Details
13.2.2 Abbvie Business Overview
13.2.3 Abbvie Specialty Pharmaceuticals Introduction
13.2.4 Abbvie Revenue in Specialty Pharmaceuticals Business (2015-2020)
13.2.5 Abbvie Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Specialty Pharmaceuticals Introduction
13.3.4 Amgen Revenue in Specialty Pharmaceuticals Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Specialty Pharmaceuticals Introduction
13.4.4 Johnson & Johnson Revenue in Specialty Pharmaceuticals Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview
13.5.3 Celgene Specialty Pharmaceuticals Introduction
13.5.4 Celgene Revenue in Specialty Pharmaceuticals Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 Gilead Sciences
13.6.1 Gilead Sciences Company Details
13.6.2 Gilead Sciences Business Overview
13.6.3 Gilead Sciences Specialty Pharmaceuticals Introduction
13.6.4 Gilead Sciences Revenue in Specialty Pharmaceuticals Business (2015-2020)
13.6.5 Gilead Sciences Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview
13.7.3 Roche Specialty Pharmaceuticals Introduction
13.7.4 Roche Revenue in Specialty Pharmaceuticals Business (2015-2020)
13.7.5 Roche Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Specialty Pharmaceuticals Key Market Segments
Table 2. Key Players Covered: Ranking by Specialty Pharmaceuticals Revenue
Table 3. Ranking of Global Top Specialty Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Specialty Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Pharmaceuticals
Table 6. Key Players of Parenteral Pharmaceuticals
Table 7. Key Players of Transdermal Pharmaceuticals
Table 8. Global Specialty Pharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Specialty Pharmaceuticals Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Specialty Pharmaceuticals Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Specialty Pharmaceuticals Market Share by Regions (2015-2020)
Table 12. Global Specialty Pharmaceuticals Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Specialty Pharmaceuticals Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Specialty Pharmaceuticals Market Growth Strategy
Table 18. Main Points Interviewed from Key Specialty Pharmaceuticals Players
Table 19. Global Specialty Pharmaceuticals Revenue by Players (2015-2020) (Million US$)
Table 20. Global Specialty Pharmaceuticals Market Share by Players (2015-2020)
Table 21. Global Top Specialty Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Pharmaceuticals as of 2019)
Table 22. Global Specialty Pharmaceuticals by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Specialty Pharmaceuticals Product Solution and Service
Table 25. Date of Enter into Specialty Pharmaceuticals Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 28. Global Specialty Pharmaceuticals Market Size Share by Type (2015-2020)
Table 29. Global Specialty Pharmaceuticals Revenue Market Share by Type (2021-2026)
Table 30. Global Specialty Pharmaceuticals Market Size Share by Application (2015-2020)
Table 31. Global Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 32. Global Specialty Pharmaceuticals Market Size Share by Application (2021-2026)
Table 33. North America Key Players Specialty Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Specialty Pharmaceuticals Market Share (2019-2020)
Table 35. North America Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 36. North America Specialty Pharmaceuticals Market Share by Type (2015-2020)
Table 37. North America Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 38. North America Specialty Pharmaceuticals Market Share by Application (2015-2020)
Table 39. Europe Key Players Specialty Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Specialty Pharmaceuticals Market Share (2019-2020)
Table 41. Europe Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Specialty Pharmaceuticals Market Share by Type (2015-2020)
Table 43. Europe Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Specialty Pharmaceuticals Market Share by Application (2015-2020)
Table 45. China Key Players Specialty Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 46. China Key Players Specialty Pharmaceuticals Market Share (2019-2020)
Table 47. China Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 48. China Specialty Pharmaceuticals Market Share by Type (2015-2020)
Table 49. China Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 50. China Specialty Pharmaceuticals Market Share by Application (2015-2020)
Table 51. Japan Key Players Specialty Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Specialty Pharmaceuticals Market Share (2019-2020)
Table 53. Japan Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Specialty Pharmaceuticals Market Share by Type (2015-2020)
Table 55. Japan Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Specialty Pharmaceuticals Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Specialty Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Specialty Pharmaceuticals Market Share (2019-2020)
Table 59. Southeast Asia Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Specialty Pharmaceuticals Market Share by Type (2015-2020)
Table 61. Southeast Asia Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Specialty Pharmaceuticals Market Share by Application (2015-2020)
Table 63. India Key Players Specialty Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 64. India Key Players Specialty Pharmaceuticals Market Share (2019-2020)
Table 65. India Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 66. India Specialty Pharmaceuticals Market Share by Type (2015-2020)
Table 67. India Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 68. India Specialty Pharmaceuticals Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Specialty Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Specialty Pharmaceuticals Market Share (2019-2020)
Table 71. Central & South America Specialty Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Specialty Pharmaceuticals Market Share by Type (2015-2020)
Table 73. Central & South America Specialty Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Specialty Pharmaceuticals Market Share by Application (2015-2020)
Table 75. Teva Pharmaceuticals Company Details
Table 76. Teva Pharmaceuticals Business Overview
Table 77. Teva Pharmaceuticals Product
Table 78. Teva Pharmaceuticals Revenue in Specialty Pharmaceuticals Business (2015-2020) (Million US$)
Table 79. Teva Pharmaceuticals Recent Development
Table 80. Abbvie Company Details
Table 81. Abbvie Business Overview
Table 82. Abbvie Product
Table 83. Abbvie Revenue in Specialty Pharmaceuticals Business (2015-2020) (Million US$)
Table 84. Abbvie Recent Development
Table 85. Amgen Company Details
Table 86. Amgen Business Overview
Table 87. Amgen Product
Table 88. Amgen Revenue in Specialty Pharmaceuticals Business (2015-2020) (Million US$)
Table 89. Amgen Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Revenue in Specialty Pharmaceuticals Business (2015-2020) (Million US$)
Table 94. Johnson & Johnson Recent Development
Table 95. Celgene Company Details
Table 96. Celgene Business Overview
Table 97. Celgene Product
Table 98. Celgene Revenue in Specialty Pharmaceuticals Business (2015-2020) (Million US$)
Table 99. Celgene Recent Development
Table 100. Gilead Sciences Company Details
Table 101. Gilead Sciences Business Overview
Table 102. Gilead Sciences Product
Table 103. Gilead Sciences Revenue in Specialty Pharmaceuticals Business (2015-2020) (Million US$)
Table 104. Gilead Sciences Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Product
Table 108. Roche Revenue in Specialty Pharmaceuticals Business (2015-2020) (Million US$)
Table 109. Roche Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Pharmaceuticals Market Share by Type: 2020 VS 2026
Figure 2. Oral Pharmaceuticals Features
Figure 3. Parenteral Pharmaceuticals Features
Figure 4. Transdermal Pharmaceuticals Features
Figure 5. Global Specialty Pharmaceuticals Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Specialty Pharmacies Case Studies
Figure 9. Mail Order Case Studies
Figure 10. Specialty Pharmaceuticals Report Years Considered
Figure 11. Global Specialty Pharmaceuticals Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Specialty Pharmaceuticals Market Share by Regions: 2020 VS 2026
Figure 13. Global Specialty Pharmaceuticals Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Specialty Pharmaceuticals Market Share by Players in 2019
Figure 16. Global Top Specialty Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Pharmaceuticals as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Specialty Pharmaceuticals Revenue in 2019
Figure 18. North America Specialty Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Specialty Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Specialty Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Specialty Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Specialty Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Specialty Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Specialty Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
特殊注射用ジェネリック医薬品の世界市場（～2026年） Market Analysis and Insights: Global Specialty Injectable Generics Market The global Specialty Injectable Generics market size is projected to reach US$ 10240 million by 2026, from US$ 9378.7 million in 2020, at a CAGR of 8.4%% during 2021-2026. Global Specialty Injectable Generics Scope and Market …- 特殊糖の世界市場（～2026年） Sugar is one of the most prevalent commodities in today’s world. However, this white crystal looking simple sweetener journeyed through ages and across almost every possible trade routes prevalent in historical world before it became common in kitchens in every home. Increase in confectionery indust…
- スペシャルティシュガーの世界市場（～2026年） Market Analysis and Insights: Global Specialty Sugar Market The global Specialty Sugar market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Specialty Sugar Scope and Market Size Specialty Sugar market is segmented by Type, …
- 向精神薬の世界市場（～2026年） Psychotropic pharmaceutical is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition or behavior. The global psychotropic pharmaceuticals market is expected to grow rapidly over the forecast period owing to the raising prevalence of…
- 水疱性類天疱瘡治療の世界市場（～2026年） Bullous pemphigoid is a chronic, inflammatory skin disease that involves the formation of blisters. The bullous may be of different forms such as generalized, vesicular, vegetative, Urticarial, Nodular, Acral or infant forms. The disease is not gender biased and can also occur in younger adults but …